Patent Expiry

Patent/Exclusivity Expiry: VALCHLOR

Other upcoming events for SNGX

Phase 3 ReadoutPhase 3 Topline: A Confirmatory Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effica

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: VALCHLOR — SNGX Patent Expiry | BioSniper